Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "intestinal fluid retention via osmotic effect" refers to the process by which poorly absorbed or non-absorbable substances in the intestinal lumen create an osmotic gradient, causing water to be retained within the gut. This leads to increased water content in the stool, resulting in softer stools or diarrhea. This mechanism is exploited by several osmotic laxatives (such as polyethylene glycol, lactulose, sorbitol, and magnesium salts) for the treatment of constipation or for diagnostic bowel cleansing. It also underlies some forms of diarrhea—especially when non-digestible solutes are retained in the bowel—by drawing water into the intestine until the osmotic load is removed.
Increase luminal osmolality to draw water into the intestine by osmotic gradient
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal fluid retention via osmotic effect.